Digital Health Global

MAY 21, 2024

With access to these collective resources and by capitalizing on existing biosamples as well as clinical data, including that from digital health technology, researchers will focus on identifying and validating biomarkers and therapeutic targets specific to ALS.

Life Science 88

Life Science Drug Development Digital Health Health Technology 88

Digital Health Global

JANUARY 8, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI respectively. Medable, which ranked in the top 8% of software companies on the 2023 Inc.

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

Digital Health Global

APRIL 16, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI for an investment on average of $500K in Phase II and $1.5M

Drug Development 88

Drug Development Pharmaceuticals Health science Digital Health 88

Digital Health Global

JUNE 20, 2023

Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.

Life Science 88

Life Science Drug Development BioTech Pharmaceuticals 88

Digital Health Global

JANUARY 31, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI for an investment of on average of $500K in Phase 2 and $1.5M in Phase 3.

Health science 88

Health science Drug Development Digital Health Patient Experience 88

Digital Health Global

SEPTEMBER 27, 2023

With these resources, Automera is well positioned to deploy our AUTAC platform toward the development of potentially transformative therapies.” ClavystBio was conceived and launched by Temasek to be a venture builder, trusted partner, and keystone to catalyze global health solutions from Singapore.

Life Science 88

Life Science Drug Development HC BioTech 88

Digital Health Global

FEBRUARY 16, 2023

“Avilar is pioneering the next frontier in protein degradation and we are excited that our significant progress over the past year in discovering and advancing extracellular protein degraders has attracted this group of leading investors,” said Daniel Grau, CEO and President of Avilar Therapeutics. Find out more: www.sanofiventures.com.

Life Science 88

Life Science BioTech Drug Development Digital Health 88

Lloyd Price

NOVEMBER 21, 2023

Engage with Stakeholders: Actively engage with NHS staff, patients, and advocacy groups to understand their concerns and address them proactively. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk Subscribe Today!

Drug Development 69

Drug Development Health science healthcare technology Leadership 69

Lloyd Price

APRIL 27, 2024

It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. But how can healthcare organisations best leverage this technology? Subscribe Today!

healthcare technology 72

healthcare technology Leadership Drug Development Digital Health 72

Healthcare Innovation Consortium

OCTOBER 24, 2023

We aim to bring together relevant stakeholders, including payers, providers, patients groups, and biotech and when and where needed we cooperate with pharma, to be the one voice of the industry. The pipeline for new antibiotics is limited, which is partly due to how new drug development is funded.

BioTech 60

BioTech Drug Development Healthcare Innovation Medical Technology 60

Digital Health Today

AUGUST 7, 2019

DTx could be used in phase II of clinical trials for monitoring patients, helping reduce costs of drug development and speeding up that phase. Healthcare professionals are a very important group to adopt DTx but education is essential for them to understand the benefits and how to use DTx. What should be the best market access?

Pharmaceuticals 70

Pharmaceuticals Digital Health Drug Development Primary Care 70

Healthcare IT News - Telehealth

MAY 6, 2020

Bardy Diagnostics is a digital health and remote patient monitoring company focused on addressing a long-standing complaint by cardiac electrophysiologists and cardiologists regarding their frequent inability to clearly distinguish the P-wave on ECG strips of existing monitors. And the list will continue to be updated over time.

Connected Health 188

Connected Health Telehealth Pharmaceuticals EHR 188